by Guy S Eakin
While research into the causes of Lipedema progresses, we know patients and health care workers are still looking for what can be done today to improve the lives of people with Lipedema. This is often a trial and error process. Unfortunately, the trials and errors are not just in trying the right treatment, but even in finding which treatment to try. The level of poor information out there for women with Lipedema is tremendous, and often a therapeutic approach to Lipedema includes sifting through mountains of testimonials and anecdotes to find reliable data. As we bring 2020 to a close, we are taking a look at the Lipedema research that particularly excited us this year because of what it’s doing to help control that problem.
We would like to start our last blog for the year by pausing to celebrate a new study that carefully evaluates treatments Lipedema patients are already receiving. When we review research, we often look for specific things. In this article, we were looking for words and phrases like “statistical power,” “blinding,” and “effect size.” These loosely translate to: “Was the study large enough?”, “Did the investigators reduce opportunities for bias?”, and “Was the effect of the treatment large enough that a patient might notice the difference?”